Alpha Cognition Return on Tangible Equity 2020-2024 | ACOG
Current and historical return on tangible equity values for Alpha Cognition (ACOG) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
| Alpha Cognition Return On Tangible Equity Historical Data |
| Date |
TTM Net Income |
Tangible Equity |
Return on Tangible Equity |
| 2024-06-30 |
$-0.02B |
$-0.00B |
457.14% |
| 2024-03-31 |
$-0.02B |
$0.00B |
523.08% |
| 2023-12-31 |
$-0.01B |
$-0.01B |
466.67% |
| 2023-09-30 |
$-0.01B |
$-0.01B |
533.33% |
| 2023-06-30 |
$-0.01B |
$-0.00B |
4400.00% |
| 2023-03-31 |
$-0.01B |
$0.00B |
-1100.00% |
| 2022-12-31 |
$-0.01B |
$-0.00B |
-533.33% |
| 2022-09-30 |
$-0.01B |
$0.00B |
-231.58% |
| 2022-06-30 |
$-0.01B |
$0.00B |
-273.68% |
| 2022-03-31 |
$-0.01B |
$0.01B |
-307.69% |
| 2021-12-31 |
$-0.02B |
$0.01B |
-1520.00% |
| 2021-09-30 |
$-0.02B |
$0.00B |
1800.00% |
| 2021-06-30 |
$-0.02B |
$-0.00B |
1200.00% |
| 2021-03-31 |
$-0.02B |
$-0.00B |
2266.67% |
| 2020-12-31 |
$-0.01B |
$-0.00B |
2400.00% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED-BIOMED/GENE |
$0.035B |
$0.000B |
|
Alpha Cognition Inc. is a clinical stage biopharmaceutical company. It involved in developing treatments for under-served neurodegenerative diseases, such as Alzheimer's Dementia and Amyotrophic Lateral Sclerosis. Alpha Cognition Inc. is based in Vancouver, British Columbia.
|
